PEGASUS-ACM Trademark

Trademark Overview


On Wednesday, June 28, 2023, a trademark application was filed for PEGASUS-ACM with the United States Patent and Trademark Office. The USPTO has given the PEGASUS-ACM trademark a serial number of 98062625. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 11, 2024. This trademark is owned by Rocket Pharmaceuticals GmbH. The PEGASUS-ACM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing information in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy; providing information in the field of arrhythmogenic cardiomyopathy; Providing links to the web sites of others featuring information about arrhythmogenic cardiomyopathy; providing links to the web sites of others in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy

Research and development of pharmaceuticals for the treatment of arrhythmogenic cardiomyopathy; medical and scientific research services in the field of arrhythmogenic cardiomyopathy; compiling patient data for research purposes in the field of pharmaceutical research and development for the treatment of arrhythmogenic cardiomyopathy
pegasus-acm

General Information


Serial Number98062625
Word MarkPEGASUS-ACM
Filing DateWednesday, June 28, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, November 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Pseudo MarkPEGASUS ARRHYTHMOGENIC CARDIOMYOPATHY
Goods and ServicesProviding information in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy; providing information in the field of arrhythmogenic cardiomyopathy; Providing links to the web sites of others featuring information about arrhythmogenic cardiomyopathy; providing links to the web sites of others in the field of the diagnosis and treatment of arrhythmogenic cardiomyopathy
Goods and ServicesResearch and development of pharmaceuticals for the treatment of arrhythmogenic cardiomyopathy; medical and scientific research services in the field of arrhythmogenic cardiomyopathy; compiling patient data for research purposes in the field of pharmaceutical research and development for the treatment of arrhythmogenic cardiomyopathy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 31, 2023
Primary Code042
First Use Anywhere DateThursday, January 12, 2023
First Use In Commerce DateThursday, January 12, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 31, 2023
Primary Code044
First Use Anywhere DateThursday, January 12, 2023
First Use In Commerce DateThursday, January 12, 2023

Trademark Owner History


Party NameRocket Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events


Event DateEvent Description
Saturday, July 1, 2023NEW APPLICATION ENTERED
Monday, July 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 13, 2024ASSIGNED TO EXAMINER
Friday, March 15, 2024NON-FINAL ACTION WRITTEN
Friday, March 15, 2024NON-FINAL ACTION E-MAILED
Friday, March 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 30, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, May 30, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER